Variant report

Variant	rs760435
Chromosome Location	chr21:46302872-46302873
allele	C/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:10)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:10 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr21:46299899..46304790-chr21:46308846..46313230,4	K562	blood:
2	chr21:46296431..46298855-chr21:46300114..46303046,3	K562	blood:
3	chr21:46220171..46223743-chr21:46298474..46302902,5	MCF-7	breast:
4	chr21:46296431..46298316-chr21:46299911..46303046,4	K562	blood:
5	chr21:46302796..46304799-chr21:46319469..46322179,2	MCF-7	breast:
6	chr21:46300926..46303863-chr21:46305072..46307882,3	K562	blood:
7	chr21:46292064..46297590-chr21:46299437..46304733,9	MCF-7	breast:
8	chr21:46227491..46230119-chr21:46302500..46304134,2	MCF-7	breast:
9	chr21:46300718..46303390-chr21:46325614..46327160,2	MCF-7	breast:
10	chr21:46302013..46304883-chr21:46310101..46313045,3	K562	blood:

No data

Variant related genes	Relation type
ENSG00000236519	Chromatin interaction
ENSG00000184787	Chromatin interaction
ENSG00000183255	Chromatin interaction
ENSG00000160255	Chromatin interaction

Extended variants
information (count: 26 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:11)

rs_ID	r²[population]
rs125810	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs170962	0.91[AMR][1000 genomes];0.98[EUR][1000 genomes];0.82[ASN][1000 genomes]
rs173093	0.85[AFR][1000 genomes]
rs235280	0.85[AFR][1000 genomes]
rs235302	0.83[AFR][1000 genomes]
rs2838724	0.98[AFR][1000 genomes];1.00[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs381406	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs440555	0.85[AFR][1000 genomes]
rs4818739	0.85[AFR][1000 genomes];0.99[AMR][1000 genomes];0.98[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs596566	0.85[AFR][1000 genomes]
rs7280520	1.00[AFR][1000 genomes];0.99[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:15 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv916258	chr21:45995986-46624705	Weak transcription Enhancers Flanking Active TSS Strong transcription Genic enhancers Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	102 gene(s)	inside rSNPs	diseases
2	nsv1062245	chr21:46096964-46332587	Active TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS ZNF genes & repeats Strong transcription Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	51 gene(s)	inside rSNPs	diseases
3	nsv544478	chr21:46096964-46332587	Enhancers Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Weak transcription Bivalent/Poised TSS Genic enhancers Strong transcription Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	51 gene(s)	inside rSNPs	diseases
4	nsv913962	chr21:46223847-46321172	Weak transcription Strong transcription Enhancers Active TSS Genic enhancers Flanking Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	34 gene(s)	inside rSNPs	diseases
5	nsv913965	chr21:46223847-46321172	Genic enhancers Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3' Flanking Active TSS Strong transcription Weak transcription ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	34 gene(s)	inside rSNPs	diseases
6	nsv1058550	chr21:46227163-46317934	Genic enhancers Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Bivalent Enhancer Enhancers ZNF genes & repeats Strong transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	33 gene(s)	inside rSNPs	diseases
7	nsv1060233	chr21:46254075-46323401	Enhancers Genic enhancers Flanking Active TSS Bivalent Enhancer Weak transcription Active TSS Strong transcription Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	21 gene(s)	inside rSNPs	diseases
8	nsv1056513	chr21:46254075-46442759	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent/Poised TSS Bivalent Enhancer Genic enhancers Strong transcription Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	32 gene(s)	inside rSNPs	diseases
9	nsv913969	chr21:46279505-46472929	Enhancers Strong transcription Bivalent/Poised TSS Weak transcription Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	31 gene(s)	inside rSNPs	diseases
10	nsv544479	chr21:46280467-46323401	Enhancers Weak transcription Genic enhancers Flanking Active TSS Strong transcription Bivalent Enhancer Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	19 gene(s)	inside rSNPs	diseases
11	nsv470907	chr21:46283669-46306161	Strong transcription Enhancers Flanking Active TSS Bivalent Enhancer Genic enhancers Active TSS Weak transcription Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	18 gene(s)	inside rSNPs	diseases
12	nsv459299	chr21:46283669-46311264	Strong transcription Active TSS Genic enhancers Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	19 gene(s)	inside rSNPs	diseases
13	nsv459300	chr21:46283669-46311264	Strong transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Active TSS Flanking Bivalent TSS/Enh Weak transcription Genic enhancers Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	19 gene(s)	inside rSNPs	diseases
14	nsv587814	chr21:46283669-46311264	Flanking Active TSS Enhancers Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Strong transcription Weak transcription Bivalent/Poised TSS Genic enhancers Bivalent Enhancer ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	19 gene(s)	inside rSNPs	diseases
15	nsv470908	chr21:46298869-46335580	Flanking Active TSS Enhancers Genic enhancers Weak transcription ZNF genes & repeats Strong transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	12 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:62 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr21:46295200-46304200	Weak transcription	Esophagus	oesophagus
2	chr21:46295600-46338800	Weak transcription	Right Atrium	heart
3	chr21:46295800-46303600	Enhancers	Primary B cells from cord blood	blood
4	chr21:46296000-46303800	Enhancers	Primary hematopoietic stem cells	blood
5	chr21:46296000-46304600	Enhancers	Primary monocytes fromperipheralblood	blood
6	chr21:46296000-46307400	Weak transcription	Rectal Smooth Muscle	rectum
7	chr21:46298200-46304200	Enhancers	Spleen	Spleen
8	chr21:46298400-46326600	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
9	chr21:46299800-46303000	Enhancers	Fetal Thymus	thymus
10	chr21:46299800-46303400	Enhancers	HSMMtube	muscle
11	chr21:46300000-46303000	Enhancers	Primary T helper cells fromperipheralblood	blood
12	chr21:46300000-46303400	Enhancers	HSMM	muscle
13	chr21:46300000-46304200	Enhancers	Placenta	Placenta
14	chr21:46300200-46303600	Enhancers	Adipose Nuclei	Adipose
15	chr21:46300200-46303800	Enhancers	HMEC	breast
16	chr21:46300200-46304600	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
17	chr21:46300400-46303000	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
18	chr21:46300400-46303000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
19	chr21:46300400-46310000	Weak transcription	Duodenum Smooth Muscle	Duodenum
20	chr21:46300600-46303200	Enhancers	NHEK	skin
21	chr21:46300600-46303600	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
22	chr21:46301000-46303000	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
23	chr21:46301000-46303200	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
24	chr21:46301000-46303600	Enhancers	Fetal Intestine Large	intestine
25	chr21:46301000-46303600	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
26	chr21:46301200-46303000	Enhancers	Fetal Intestine Small	intestine
27	chr21:46301200-46303400	Enhancers	Fetal Muscle Trunk	muscle
28	chr21:46301400-46305400	Weak transcription	Dnd41	blood
29	chr21:46301600-46303600	Flanking Active TSS	Hela-S3	cervix
30	chr21:46301600-46304600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
31	chr21:46301600-46305400	Weak transcription	Primary T regulatory cells fromperipheralblood	blood
32	chr21:46301800-46304200	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
33	chr21:46301800-46304400	Enhancers	Primary hematopoietic stem cells short term culture	blood
34	chr21:46301800-46304600	Enhancers	HepG2	liver
35	chr21:46302000-46303600	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
36	chr21:46302000-46305400	Weak transcription	Liver	Liver
37	chr21:46302200-46303000	Enhancers	Fetal Muscle Leg	muscle
38	chr21:46302200-46303400	Enhancers	Colonic Mucosa	Colon
39	chr21:46302200-46305400	Weak transcription	Thymus	Thymus
40	chr21:46302200-46308000	Weak transcription	Breast Myoepithelial Primary Cells	Breast
41	chr21:46302200-46309800	Weak transcription	Primary T helper memory cells from peripheral blood 1	blood
42	chr21:46302400-46303400	Weak transcription	Brain Substantia Nigra	brain
43	chr21:46302400-46304000	Weak transcription	Primary T cells fromperipheralblood	blood
44	chr21:46302400-46304400	Weak transcription	Brain Hippocampus Middle	brain
45	chr21:46302400-46305400	Weak transcription	Primary T helper 17 cells PMA-I stimulated	--
46	chr21:46302400-46305400	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
47	chr21:46302400-46305800	Weak transcription	Primary T killer naive cells fromperipheralblood	blood
48	chr21:46302400-46306000	Weak transcription	Primary T helper memory cells from peripheral blood 2	blood
49	chr21:46302400-46309600	Weak transcription	Primary T killer memory cells from peripheral blood	blood
50	chr21:46302600-46305400	Weak transcription	Primary T cells from cord blood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links